Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma

Thyroid

Volumn 21, Issue 12, 2011, Pages 1309-1316

  Clayman, Gary L ^a   Agarwal, Garima ^a   Edeiken, Beth S ^a   Waguespack, Steven G ^a   Roberts, Dianna B ^a   Sherman, Steven I ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROGLOBULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CHILD; CYTODIAGNOSIS; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT LARYNGEAL NERVE PALSY; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME; VISCERAL METASTASIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CHI-SQUARE DISTRIBUTION; CHILD; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPOPARATHYROIDISM; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TEXAS; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; VOCAL CORD PARALYSIS; YOUNG ADULT;

EID: 82955161604     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0170     Document Type: Article

References (14)

1. American Joint Committee on Cancer 2009 AJCC Cancer Staging Manual. Seventh edition. Springer Press, New York.
2. Cady B, Rossi R 1988 An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104:947-953. (Pubitemid 19011971)
3. Shaha AR, Loree TR, Shah JP 1994 Intermediate-risk group for differentiated carcinoma of the thyroid. Surgery 116:1036-1041. (Pubitemid 24382163)
4. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS 1993 Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050-1058. (Pubitemid 24004722)
5. Hundahl SA, Cady B, Cunningham MP, Mazzaferri E, McKee RF, Rosai J, Shah JP, Fremgen AM, Stewart AK, Holzer S 2000 Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study. Cancer 89:202-217. (Pubitemid 30451292)
6. Sherman SI, Angelos P, Ball DW, Beenken SW, Byrd D, Clark OH, Daniels GH, Dilawari RA, Ehya H, Farrar WB, Gagel RF, Kandeel F, Kloos RT, Kopp P, Lamonica DM, Loree TR, Lydiatt WM, McCaffrey J, Olson JA, Jr., Ridge JA, Robbins R, Shah JP, Sisson JC, Thompson NW, National Comprehensive Cancer Network 2005 Thyroid carcinoma. J Natl Compr Cancer Netw 3:404-457.
7. Clayman GC, Shellenberger TD, Ginsberg LE, Edeiken BS, El-Naggar AK, Sellin RV, Waguespack SG, Roberts DB, Mishra A, Sherman SI 2009 Approach and safety of comprehensive central compartment dissection in patients with recurrent thyroid cancer. Head Neck 9:1152-1163.
8. Carty SE, Cooper DS, Doherty GM, Duh QY, Kloos RT, Mandel SJ, Randolph GW, Stack BC, Jr., Steward DL, Terris DJ, Thompson GB, Tufano RP, Tuttle RM, Udelsman R 2009 Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 19:1153-1158.
9. Waseem Z, Palme CE, Walfish P, Freeman JL 2004 Prognostic implications of site of recurrence in patients with recurrent well-differentiated thyroid cancer. J Otolaryngol 33:339-344. (Pubitemid 40395387)
10. Kim MK, Mandel SH, Balock A, Livolsi VA, Langer JE, Didanato L, Fish S, Weber RS 2004 Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg 130:1214-1216. (Pubitemid 39371970)
11. Schuff KG, Weber SM, Givi B, Samuels MH, Andersen PE, Cohen JI 2008 Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer. Laryngoscope 118:768-775. (Pubitemid 351631273)
12. Samaan NA, Schulz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, Ordonex, NG 1992 The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab 75:714-720.
13. Breaux GP, Guillamondegui OM 1980 Treatment of locally invasive carcinoma of the thyroid: how radical? Am J Surg 140:514-517.
14. Schwartz DL, LoboMJ, Ang KK,MorrisonWH, Rosenthal DI, Ahamad A, Evans DB, Clayman G, Sherman SI, Garden AS 2009 Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment. Int J Radiat Oncol Biol Phys 74:1083-1091.